Founded as a University of Oxford spinout in 2012, Brainomix creates AI imaging biomarkers for precision medicine. The company's main products include Brainomix 360 Stroke (analyzing brain scans via NCCT, CTA, CTP and MRI), Brainomix 360 e-Lung (FDA-cleared for CT lung scans), and Vantage (a network analytics dashboard). The platforms are deployed across 20+ countries in regional hospitals and academic centres, with clinical evidence from 80+ peer-reviewed publications and 3.5M+ scans analyzed.
Brainomix works with healthcare partners and life sciences companies on clinical trials, including partnerships with organizations like Boehringer Ingelheim. The company emphasizes ethical AI, patient safety, and responsible innovation in healthcare systems.
This is the employer describing itself, in its own words. We do not rate or review employers, and nothing here is our opinion of one.